This information was published on 2026-10-23T13:00:13 for IP Right Filed Published.
| Field | Value |
| (210) | 2708504 |
| (220) |
23 Oct 2026
|
| (300) |
US, 22 Oct 2026, 50176555
|
| (511) (510) |
Class 5
Pharmaceutical products for the treatment of cancer; Antibodies for medical purposes; Tumor suppressing agents; Therapeutic pharmaceuticals for the treatment cancer; Biologics in the nature of pharmaceutical preparations for the treatment of cancer Class 42 Medical and scientific research in the field of oncology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| (540) | FYQORA |
| (550) | Word |
| (730) |
Bicara Therapeutics Inc.
|
| (750) |
FB Rice Pty Ltd
|
Find out more about publications on the About page.